"neoadjuvant chemoradiotherap" trang 14 - tải miễn phí từ tailieunhanh
Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: Longitudinal expression, transcriptome-level effects and modulation of chemosensitivity

Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: Longitudinal expression, transcriptome-level effects and modulation of chemosensitivity
15    16    1
Initial and ten-year treatment patterns among 11,000 breast cancer patients undergoing breast surgery-an analysis of German claims data

Initial and ten-year treatment patterns among 11,000 breast cancer patients undergoing breast surgery-an analysis of German claims data
12    12    1
Robotic transthoracic esophagectomy versus thoracoscopic esophagectomy in combined with laparoscopy for esophageal cancer

Robotic transthoracic esophagectomy versus thoracoscopic esophagectomy in combined with laparoscopy for esophageal cancer
9    1    1
Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): Study protocol for a multicenter randomized controlled trial

Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): Study protocol for a multicenter randomized controlled trial
8    1    1
Final analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant setting

Final analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant setting
9    6    1
Real-world management and outcomes of older patients with locally advanced esophageal squamous cell carcinoma: A multicenter retrospective study

Real-world management and outcomes of older patients with locally advanced esophageal squamous cell carcinoma: A multicenter retrospective study
11    2    1
A prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: Protocol of Surgery As Needed for Oesophageal cancer-2

A prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: Protocol of Surgery As Needed for Oesophageal cancer-2
10    5    1
Does resection after neoadjuvant chemotherapy of docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? a multicenter, prospective cohort study (Neo-REGATTA)

Does resection after neoadjuvant chemotherapy of docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? a multicenter, prospective cohort study (Neo-REGATTA)
8    4    1
A multi‑centre randomized controlled trial investigating Consolidation Chemotherapy with and without oxaliplatin in distal rectal cancer and Watch & Wait

A multi‑centre randomized controlled trial investigating Consolidation Chemotherapy with and without oxaliplatin in distal rectal cancer and Watch & Wait
10    7    1
FAP, CD10, and GPR77-labeled CAFs cause neoadjuvant chemotherapy resistance by inducing EMT and CSC in gastric cancer

FAP, CD10, and GPR77-labeled CAFs cause neoadjuvant chemotherapy resistance by inducing EMT and CSC in gastric cancer
15    7    1
Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)

Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
7    1    1
The prognostic significance of the circumferential resection margin in esophageal squamous cell carcinoma patients without neoadjuvant treatment

The prognostic significance of the circumferential resection margin in esophageal squamous cell carcinoma patients without neoadjuvant treatment
12    2    1
Prognostic value of a modified systemic inflammation score in breast cancer patients who underwent neoadjuvant chemotherapy

Prognostic value of a modified systemic inflammation score in breast cancer patients who underwent neoadjuvant chemotherapy
15    1    1
Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resection

Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resection
8    1    1
A new model of preoperative systemic inflammatory markers predicting overall survival of osteosarcoma: A multicenter retrospective study

A new model of preoperative systemic inflammatory markers predicting overall survival of osteosarcoma: A multicenter retrospective study
9    2    1
Prognostic significance of inflammatory and nutritional markers in perioperative period for patients with advanced gastric cancer

Prognostic significance of inflammatory and nutritional markers in perioperative period for patients with advanced gastric cancer
11    7    1
Preoperative sequential short-course radiation therapy and FOLFOX chemotherapy versus long-course chemoradiotherapy for locally advanced rectal cancer: A multicenter, randomized controlled trial (SOLAR trial)

Preoperative sequential short-course radiation therapy and FOLFOX chemotherapy versus long-course chemoradiotherapy for locally advanced rectal cancer: A multicenter, randomized controlled trial (SOLAR trial)
9    3    1
Analysis of treatment outcomes according to the cycles of adjuvant chemotherapy in gastric cancer: A retrospective nationwide cohort study

Analysis of treatment outcomes according to the cycles of adjuvant chemotherapy in gastric cancer: A retrospective nationwide cohort study
8    1    1
Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer

Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer
9    1    1
NEOADJUVANT CHEMOTHERAPY – CURRENT APPLICATIONS IN CLINICAL PRACTICE

NEOADJUVANT CHEMOTHERAPY – CURRENT APPLICATIONS IN CLINICAL PRACTICE

268    74    0